Dana-Farber’s Breast Oncology Center
@DFCI_BreastOnc
Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425
ID:1491159909794291720
https://www.dana-farber.org/breast-oncology-program/ 08-02-2022 21:20:39
4,1K Tweets
4,5K Followers
338 Following
Follow People
Hope Rugo Paolo Tarantino evaluate TROP2-directed therapy in hormone receptor-positive metastatic #breastcancer in this two-part #CME panel discussion.
#PeerVoice #oncology #TROP2 #antibodydrugconjugates
peervoice.com/UGT?PromoCode=…
Dr. Tarantino (Paolo Tarantino) and Dr. O’Shaughnessy discuss unmet needs for pts with HR+/HER2- advanced #BreastCancer in this video
Join us for our Post-ASCO 2024 Highlights 📣🩸
Featuring presentations & panel discussions on selected abstracts from #ASCO 2024 🔦
Agendas available soon 📝
REGISTER 👉 vjoncology.com/feature/post-a…
#ASCO 24 Sanjay Popat Tom Powles Sara Tolaney Lizzy Smyth
Our study characterizing breast cancer brain metastasis is officially out in PNASNews. We reproted breast cancer-stromal cells interaction induces resistance to HER2-targeting agents via bulky glycoproteins. Congrats to Marie-Anne Goyette and Kornelia Polyak.
pnas.org/doi/abs/10.107…
New study recently published in JAMA Oncology on Second Primary #BreastCancer in Young Breast Cancer Survivors read the full text here:
jamanetwork.com/journals/jamao…
Ann Partridge MD, MPH #KristenBrantley Shoshana Rosenberg Kathryn Ruddy Rulla Tamimi Lidia Schapira
The U.S. Preventive Services Task Force now recommends women get biennial mammograms starting at age 40. Dana-Farber's Ann Partridge MD, MPH joined NBC10 Boston to discuss the new guidelines:
ms.spr.ly/6016Yub9e
Thrilled to be exhibiting at #ASCO24 ! 🎉
We’ll be showcasing new data highlighting our NeXT Personal® platform📊
Visit our talks and posters listed below 🗣
(@RoyalMarsdenNHS, The ICR, Vall d’Hebron Institute of Oncology (VHIO), Duke Health, Dana-Farber, and BC Cancer)
#PrecisionOncology #ImmunoTherapy #ctDNA
We are leading a phase 2 trial, called #TRADE , to assess if a brief dose escalation of adjuvant #abemaciclib w/ ongoing endocrine therapy reduces side effects & improves tolerability in patients with early-stage HR-positive and HER2-negative #BreastCancer .
dana-farber.org/clinical-trial…
For Couples: Virtual Sexual Health Workshop
🗓️May 9 | 7-8:30 pm ET
Dr. Bober (Sharon L Bober) will address common changes that may affect couples after a #breastcancer diagnosis and provide ways to improve communication.
redcap.partners.org/redcap/surveys…
Learn about the design and implementation of an opt-out, end-to-end, preemptive DPYD testing program for patients planned for a systemic fluoropyrimidine in this recent JCO Oncology Practice publication.
Craig Bunnell, MD #CarolineBlock Doug Rubinson
👉pubmed.ncbi.nlm.nih.gov/38608224/
Thank you to all who attended the 2024 Reves International Breast Cancer Symposium and a special thanks to the amazing speakers for bringing forward their insightful work as we all collaborate to end breast cancer. Carlos L. Arteaga, M.D. Debb Farr Heather McArthur, MD, MPH
Kate Santos, one of our rising💫Clinical Research Coordinators, currently working in Heather Parsons' lab, visited Bunker Hill Community College to speak with #STEM students about her current role and to discuss careers in oncology and research.
#PeerToPeerEducation #womeninSTEM
Check out our newest treatment guideline on the use of low-dose tamoxifen in patients with estrogen receptor-positive (ER+) ductal carcinoma in situ #DCIS #BOCGuideline #CancerGuideline
#DuctalCarcinomaInSitu Brittany Bychkovsky, MD Tari King MD Dr. E Mittendorf
👇👇
physicianresources.dana-farber.org/flexpaper/trea…
Dr. Tomás Pascual, will be co-presenting an educational talk alongside Sara Tolaney and Tatiana Prowell, MD - Aleix Prat #PrecisionOncology
ESMO - Eur. Oncology Hospital Clínic IDIBAPS Universitat de Barcelona SOLTI #cancerresearch
#Cancer #ESMO #ESMO 2024 #OncoDaily #Oncology
oncodaily.com/61692.html